Neonc Technologies Holdings, Inc.(NTHI)

Biotechnology · Calabasas, CA

$3.01+0.09 (+3.08%)

Delayed quote: Oct 6, 2026, 12:30 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T16:33:51.138Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:33:51.138Z.

Quote observation: 2026-10-06T16:30:36.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -21,156,676
Quote market capitalization: 78,054,917

FMP input reference: 2d3a9198413857e44d8ff08287218970dc762668c083e85858692cc7a401d48f

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NTHI Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

NTHI Competitors' Operating Cash Flow Yield

NTHI

Neonc Technologies Holdings, Inc.

Current

Market Cap

$78.05M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LUNG

Pulmonx Corporation

vs NTHI

Market Cap

$78.35M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INO

Inovio Pharmaceuticals, Inc.

vs NTHI

Market Cap

$79.11M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SERA

Sera Prognostics, Inc.

vs NTHI

Market Cap

$79.82M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTOR

Citius Oncology, Inc.

vs NTHI

Market Cap

$79.96M

Operating Cash Flow Yield

N/A

TTM Avg

0.15%

3Y Avg

0.15%

5Y Avg

0.15%

Outset Medical, Inc.

vs NTHI

Market Cap

$76.13M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SKIN

SkinHealth Systems Inc.

vs NTHI

Market Cap

$75.91M

Operating Cash Flow Yield

28.93%

TTM Avg

26.53%

3Y Avg

15.21%

5Y Avg

15.21%

HYPR

Hyperfine, Inc.

vs NTHI

Market Cap

$74.77M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NTRB

Nutriband Inc.

vs NTHI

Market Cap

$82.05M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MNOV

MediciNova, Inc.

vs NTHI

Market Cap

$82.45M

Operating Cash Flow Yield

N/A

TTM Avg

0.91%

3Y Avg

0.91%

5Y Avg

0.91%

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Neonc Technologies Holdings, Inc. (NTHI)	$78.05M	N/A	N/A	N/A	N/A
Pulmonx Corporation (LUNG)vs ›	$78.35M	N/A	N/A	N/A	N/A
Inovio Pharmaceuticals, Inc. (INO)vs ›	$79.11M	N/A	N/A	N/A	N/A
Sera Prognostics, Inc. (SERA)vs ›	$79.82M	N/A	N/A	N/A	N/A
Citius Oncology, Inc. (CTOR)vs ›	$79.96M	N/A	0.15%	0.15%	0.15%
Outset Medical, Inc. (OM)vs ›	$76.13M	N/A	N/A	N/A	N/A
SkinHealth Systems Inc. (SKIN)vs ›	$75.91M	28.93%	26.53%	15.21%	15.21%
Hyperfine, Inc. (HYPR)vs ›	$74.77M	N/A	N/A	N/A	N/A
Nutriband Inc. (NTRB)vs ›	$82.05M	N/A	N/A	N/A	N/A
MediciNova, Inc. (MNOV)vs ›	$82.45M	N/A	0.91%	0.91%	0.91%

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

NTHI Operating Cash Flow Yield Metrics

NTHI Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics